Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Codeine	O
/	O
Sulfa	O
(Sulfonamide	O
Antibiotics)	O
/	O
Hydrochlorothiazide	O
/	O
Oxycodone	O
/	O
Pioglitazone	O
/	O
Clarithromycin	O
/	O
latex	O
Attending:	O
___.	O
Chief	O
Complaint:	O
NSTEMI	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
___:	O
coronary	O
angiogram	O
History	O
of	O
Present	O
Illness:	O
___	O
F	O
with	O
CAD	O
s/p	O
CABGx3,	O
HTN,	O
DM,	O
COPD,	O
CHF,	O
and	O
AVR	O
presenting	O
with	O
chest	O
pain.	O
Patient	O
woke	O
up	O
with	O
pain	O
at	O
2AM	O
this	O
morning.	O
Began	O
as	O
a	O
substernal	O
pain,	O
began	O
to	O
radiate	O
bilaterally	O
toward	O
the	O
lateral	O
chest	O
without	O
involvement	O
of	O
the	O
shoulders.	O
Pain	O
is	O
a	O
___,	O
initially	O
improved	O
with	O
SL	O
nitro	O
in	O
the	O
AM,	O
then	O
___	O
more	O
times	O
afterward	O
without	O
exertion	O
throughout	O
the	O
day.	O
Went	O
to	O
___	O
office	O
with	O
symptoms,	O
had	O
EKG,	O
and	O
was	O
sent	O
in	O
for	O
further	O
evaluation.	O
At	O
that	O
time	O
her	O
pain	O
was	O
persistent,	O
without	O
improvement	O
with	O
SL	O
nitro.	O
Not	O
associated	O
with	O
any	O
nausea,	O
vomiting,	O
headache,	O
visual	B-Visual_impairment
abnormalities,	B-Visual_impairment
or	O
dizziness.	O
ED	O
evaluated	O
for	O
ACS,	O
started	O
on	O
full	O
dose	O
ASA,	O
initially	O
had	O
no	O
signs	O
of	O
acute	O
ischemia	O
on	O
EKG.	O
Second	O
set	O
of	O
troponins	O
positive	O
to	O
0.13,	O
and	O
patient	O
was	O
started	O
on	O
heparin	O
gtt	O
for	O
NSTEMI	O
and	O
admitted	O
for	O
further	O
treatment	O
and	O
evaluation.	O
-	O
Initial	O
vitals:	O
___	O
11:29	O
97.1F,	O
76,	O
165/95,	O
18,	O
99%	O
on	O
2L	O
-	O
EKG:	O
LVH,	O
poor	O
R	O
wave	O
progression	O
in	O
V3-V6,	O
T	O
wave	O
flattening	O
in	O
V3,	O
no	O
evidence	O
of	O
acute	O
ischemia,	O
unchanged	O
from	O
prior	O
___	O
-	O
Labs/studies	O
notable	O
for:	O
WBC	O
8.2,	O
Hgb	O
10.6,	O
Plt	O
184	O
Na	O
142,	O
K	O
4.1,	O
Cl	O
105,	O
HCO3	O
23,	O
BUN	O
40,	O
Cr	O
1.2	O
TnT	O
<	O
0.01,	O
then	O
0.13	O
Mg	O
1.9	O
UA	O
100	O
protein,	O
otherwise	O
unremarkable	O
-	O
Patient	O
was	O
given:	O
___	O
14:08	O
PO	O
Aspirin	O
243	O
mg	O
___	O
21:16	O
IV	O
Furosemide	O
20	O
mg	O
___	O
21:40	O
IV	O
Heparin	O
4000	O
UNIT	O
___	O
21:40	O
IV	O
Heparin	O
Started	O
850	O
units/hr	O
-	O
Vitals	O
on	O
transfer:	O
___	O
97.5F,	O
70,	O
175/62,	O
18,	O
99%	O
on	O
RA	O
On	O
the	O
floor	O
patient	O
feels	O
well.	O
She	O
verified	O
the	O
history	O
above.	O
Took	O
SL	O
nitro	O
multiple	O
times	O
throughout	O
the	O
last	O
24	O
hours,	O
came	O
in	O
after	O
it	O
stopped	O
working.	O
REVIEW	O
OF	O
SYSTEMS:	O
10	O
point	O
ROS	O
as	O
above,	O
otherwise	O
negative.	O
Past	O
Medical	O
History:	O
1.	O
CARDIAC	O
RISK	O
FACTORS	O
-	O
Diabetes	O
-	O
Hypertension	O
-	O
Dyslipidemia	O
2.	O
CARDIAC	O
HISTORY	O
-	O
CABG:	O
3V:	O
LIMA	O
to	O
LAD,	O
SVG	O
to	O
OM1,	O
SVG	O
to	O
PDA	O
___	O
BWH)	O
-	O
PERCUTANEOUS	O
CORONARY	O
INTERVENTIONS:	O
Perioperative	O
injury	O
to	O
LIMA	O
requiring	O
PCI	O
with	O
DES,	O
ISR,	O
LAD	O
with	O
balloon	O
angioplasty.	O
-	O
PACING/ICD:	O
None	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY	O
GERD	O
Hx	O
of	O
Zoster	O
infection	O
Carpal	O
tunnel	O
obesity	O
AS	O
s/p	O
AVR	O
c/b	O
LIMA	O
resection	O
requiring	O
intra-anastomosis	O
c/b	O
post-operative	O
STEMI	O
AMI	O
s/p	O
DES	O
x2	O
hypothyroidism	O
Anemia	O
Cholelithiasis	O
CKD	O
III	O
Restrictive	O
+	O
obstructive	O
lung	O
disease	O
Asthma	O
HFpEF	O
(50-55%	O
___	O
NARES	O
Atopic	O
neurodermatitis	O
Hx	O
PE	O
Hx	O
TIA	O
Diabetic	B-Visual_impairment
retinopathy	B-Visual_impairment
Angina	O
Social	O
History:	O
___	O
Family	O
History:	O
Mom	O
and	O
dad	O
passed	O
away	O
from	O
MI;	O
uncle	O
has	O
DM.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM	O
=======================	O
24	O
HR	O
Data	O
(last	O
updated	O
___	O
@	O
2339)	O
Temp:	O
97.7	O
(Tm	O
97.7),	O
BP:	O
159/49,	O
HR:	O
60,	O
RR:	O
18,	O
O2	O
sat:	O
96%,	O
O2	O
delivery:	O
RA,	O
Wt:	O
158.9	O
lb/72.08	O
kg	O
GENERAL:	O
NAD,	O
appears	O
younger	O
than	O
stated	O
age	O
HEENT:	O
AT/NC,	O
anicteric	O
sclera,	O
MMM	O
NECK:	O
supple,	O
no	O
LAD	O
CV:	O
RRR,	O
S1/S2,	O
no	O
murmurs,	O
gallops,	O
or	O
rubs	O
PULM:	O
CTAB,	O
no	O
wheezes,	O
rales,	O
rhonchi,	O
breathing	O
comfortably	O
without	O
use	O
of	O
accessory	O
muscles	O
GI:	O
abdomen	O
soft,	O
nondistended,	O
nontender	O
in	O
all	O
quadrants,	O
no	O
rebound/guarding,	O
no	O
hepatosplenomegaly	O
EXTREMITIES:	O
no	O
cyanosis,	O
clubbing,	O
or	O
edema	O
PULSES:	O
2+	O
radial	O
pulses	O
bilaterally	O
NEURO:	O
Alert,	O
moving	O
all	O
4	O
extremities	O
with	O
purpose,	O
face	O
symmetric	O
DERM:	O
warm	O
and	O
well	O
perfused,	O
no	O
excoriations	O
or	O
lesions,	O
no	O
rashes	O
LABS/MICRO	O
reviewed	O
in	O
OMR.	O
DISCHARGE	O
PHYSICAL	O
EXAM	O
=======================	O
24	O
HR	O
Data	O
(last	O
updated	O
___	O
@	O
656)	O
Temp:	O
97.7	O
(Tm	O
98.4),	O
BP:	O
142/57	O
(109-175/51-70),	O
HR:	O
59	O
(55-93),	O
RR:	O
18,	O
O2	O
sat:	O
95%	O
(95-98),	O
O2	O
delivery:	O
Ra,	O
Wt:	O
161.16	O
lb/73.1	O
kg	O
Fluid	O
Balance	O
(last	O
updated	O
___	O
@	O
539)	O
Last	O
8	O
hours	O
Total	O
cumulative	O
-450ml	O
IN:	O
Total	O
0ml	O
OUT:	O
Total	O
450ml,	O
Urine	O
Amt	O
450ml	O
Last	O
24	O
hours	O
Total	O
cumulative	O
-655ml	O
IN:	O
Total	O
720ml,	O
PO	O
Amt	O
720ml	O
OUT:	O
Total	O
1375ml,	O
Urine	O
Amt	O
1375ml	O
GENERAL:	O
NAD,	O
sitting	O
up	O
in	O
bed	O
NECK:	O
supple,	O
no	O
LAD,	O
JVP	O
not	O
elevated	O
CV:	O
RRR,	O
S2	O
louder	O
than	O
S1,	O
___	O
SEM	O
heard	O
best	O
at	O
RUSB	O
PULM:	O
bibasilar	O
crackles	O
and	O
occasional	O
wheezing,	O
otherwise	O
clear.	O
No	O
increase	O
work	O
of	O
breathing	O
or	O
accessory	O
muscle	O
use	O
EXTREMITIES:	O
no	O
cyanosis,	O
clubbing.	O
L	O
leg	O
with	O
segment	O
of	O
1+	O
edema	O
above	O
sock	O
line,	O
trace	O
edema	O
of	O
bilateral	O
feet.	O
NEURO:	O
AAOx3,	B-Delirium
moving	O
all	O
4	O
extremities	O
with	O
purpose,	O
face	O
symmetric,	O
speech	O
fluent	O
PSYCH:	O
Mood	O
and	O
affect	O
appropriate	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
___	O
12:16PM	O
BLOOD	O
WBC-8.2	O
RBC-3.67*	O
Hgb-10.6*	O
Hct-32.9*	O
MCV-90	O
MCH-28.9	O
MCHC-32.2	O
RDW-14.9	O
RDWSD-47.1*	O
Plt	O
___	O
___	O
12:16PM	O
BLOOD	O
___	O
PTT-27.1	O
___	O
___	O
12:16PM	O
BLOOD	O
Glucose-150*	O
UreaN-40*	O
Creat-1.2*	O
Na-142	O
K-4.1	O
Cl-105	O
HCO3-23	O
AnGap-14	O
___	O
12:16PM	O
BLOOD	O
cTropnT-<0.01	O
___	O
06:00PM	O
BLOOD	O
cTropnT-0.13*	O
___	O
04:00AM	O
BLOOD	O
CK-MB-6	O
cTropnT-0.18*	O
proBNP-3259*	O
___	O
11:45AM	O
BLOOD	O
cTropnT-0.20*	O
___	O
11:20PM	O
BLOOD	O
CK-MB-3	O
cTropnT-0.18*	O
___	O
12:16PM	O
BLOOD	O
Calcium-8.7	O
Phos-3.1	O
Mg-1.9	O
DISCHARGE	O
LABS	O
___	O
07:30AM	O
BLOOD	O
WBC-7.6	O
RBC-3.73*	O
Hgb-10.6*	O
Hct-33.1*	O
MCV-89	O
MCH-28.4	O
MCHC-32.0	O
RDW-14.8	O
RDWSD-47.3*	O
Plt	O
___	O
___	O
07:30AM	O
BLOOD	O
Glucose-130*	O
UreaN-41*	O
Creat-1.6*	O
Na-140	O
K-4.3	O
Cl-99	O
HCO3-27	O
AnGap-14	O
___	O
07:30AM	O
BLOOD	O
Calcium-8.7	O
Phos-3.9	O
Mg-1.9	O
STUDIES	O
TTE	O
___	O
CONCLUSION:	O
The	O
left	O
atrium	O
is	O
normal	O
in	O
size.	O
There	O
is	O
normal	O
left	O
ventricular	O
wall	O
thickness	O
with	O
a	O
normal	O
cavity	O
size.	O
There	O
is	O
suboptimal	O
image	O
quality	O
to	O
assess	O
regional	O
left	O
ventricular	O
function.	O
The	O
visually	O
estimated	O
left	O
ventricular	O
ejection	O
fraction	O
is	O
>=50%.	O
Normal	O
right	O
ventricular	O
cavity	O
size	O
with	O
normal	O
free	O
wall	O
motion.	O
The	O
aortic	O
sinus	O
diameter	O
is	O
normal	O
for	O
gender	O
with	O
normal	O
ascending	O
aorta	O
diameter	O
for	O
gender.	O
The	O
aortic	O
valve	O
leaflets	O
(?#)	O
appear	O
structurally	O
normal.	O
There	O
is	O
no	O
aortic	O
valve	O
stenosis.	O
There	O
is	O
no	O
aortic	O
regurgitation.	O
The	O
mitral	O
valve	O
leaflets	O
appear	O
structurally	O
normal.	O
There	O
is	O
moderate	O
mitral	O
annular	O
calcification.	O
There	O
is	O
mild	O
[1+]	O
mitral	O
regurgitation.	O
Due	O
to	O
acoustic	O
shadowing,	O
the	O
severity	O
of	O
mitral	O
regurgitation	O
could	O
be	O
UNDERestimated.	O
The	O
tricuspid	O
valve	O
is	O
not	O
well	O
seen.	O
The	O
pulmonary	O
artery	O
systolic	O
pressure	O
could	O
not	O
be	O
estimated.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
IMPRESSION:	O
Very	O
poor	O
image	O
quality.	O
Normal	O
biventricular	O
wall	O
thicknesses,	O
cavity	O
sizes,	O
and	O
global	O
systolic	O
function.	O
MIld	O
mitral	O
regurgitation.	O
Compared	O
with	O
the	O
prior	O
TTE	O
(images	O
reviewed)	O
of	O
___	O
,	O
apical	O
dysfunction	O
is	O
not	O
suggested	O
on	O
the	O
current	O
study,	O
but	O
image	O
quality	O
is	O
very	O
poor.	O
RECOMMEND:	O
If	O
clinically	O
indicated,	O
a	O
cardiac	O
MR	O
or	O
MUGA	O
scan	O
is	O
suggested	O
for	O
further	O
evaluation	O
of	O
regional/global	O
systolic	O
function.	O
Cardiac	O
MR	O
with	O
gadolinium	O
would	O
also	O
allow	O
for	O
assessment	O
for	O
prior	O
infarction.	O
___	O
Coronary	O
Catheterization	O
Coronary	O
Description	O
The	O
coronary	O
circulation	O
is	O
right	O
dominant.	O
LM:	O
The	O
Left	O
Main,	O
arising	O
from	O
the	O
left	O
cusp,	O
is	O
a	O
large	O
caliber	O
vessel	O
with	O
p[reviously	O
deployed	O
stents	O
extneding	O
into	O
proximal	O
LAD.	O
This	O
vessel	O
bifurcates	O
into	O
the	O
Left	O
Anterior	O
Descending	O
and	O
Left	O
Circumflex	O
systems.	O
There	O
is	O
a	O
30%	O
in-stent	O
restenosis	O
in	O
the	O
proximal,	O
mid,	O
and	O
distal	O
segments.	O
LAD:	O
The	O
Left	O
Anterior	O
Descending	O
artery,	O
which	O
arises	O
from	O
the	O
LM,	O
is	O
a	O
large	O
caliber	O
vessel.	O
There	O
is	O
a	O
50%	O
stenosis	O
in	O
the	O
proximal	O
segment	O
within	O
previously	O
deployed	O
stents.	O
There	O
is	O
a	O
100%	O
stenosis	O
in	O
the	O
mid	O
segment.	O
The	O
Septal	O
Perforator,	O
arising	O
from	O
the	O
mid	O
segment,	O
is	O
a	O
small	O
caliber	O
vessel.	O
The	O
Diagonal,	O
arising	O
from	O
the	O
mid	O
segment,	O
is	O
a	O
medium	O
caliber	O
vessel.	O
Cx:	O
The	O
Circumflex	O
artery,	O
which	O
arises	O
from	O
the	O
LM,	O
is	O
a	O
large	O
caliber	O
vessel.	O
There	O
is	O
a	O
100%	O
stenosis	O
in	O
the	O
proximal	O
segment.	O
The	O
Obtuse	O
Marginal,	O
arising	O
from	O
the	O
mid	O
segment,	O
is	O
a	O
medium	O
caliber	O
vessel.	O
RCA:	O
The	O
Right	O
Coronary	O
Artery,	O
arising	O
from	O
the	O
right	O
cusp,	O
is	O
a	O
small	O
caliber	O
vessel.	O
There	O
is	O
an	O
80%	O
diffuse	O
stenosis	O
in	O
the	O
mid	O
segment.	O
There	O
is	O
an	O
80%	O
stenosis	O
in	O
the	O
distal	O
segment.	O
The	O
Right	O
Posterolateral	O
Artery,	O
arising	O
from	O
the	O
distal	O
segment,	O
is	O
a	O
medium	O
caliber	O
vessel.	O
The	O
Right	O
Posterior	O
Descending	O
Artery,	O
arising	O
from	O
the	O
distal	O
segment,	O
is	O
a	O
medium	O
caliber	O
vessel.	O
SVG	O
to	O
OM1	O
is	O
widely	O
patent.	O
SVG	O
to	O
PDA	O
has	O
30%	O
stenosis	O
in	O
proximal	O
segment	O
at	O
bendpoint	O
in	O
the	O
vessel.	O
Complications:	O
There	O
were	O
no	O
clinically	O
significant	O
complications.	O
Recommendations	O
Â•	O
No	O
clear	O
culprit	O
for	O
current	O
presentation.	O
Will	O
need	O
optimize	O
medical	O
therapy	O
Brief	O
Hospital	O
Course:	O
SUMMARY	O
STATEMENT	O
==================	O
___	O
with	O
history	O
of	O
3V	O
CABG,	O
CAD,	O
HTN,	O
DM,	O
HFpEF	O
presenting	O
with	O
substernal	O
chest	O
pressure	O
that	O
awoke	O
her	O
from	O
sleep	O
found	O
to	O
have	O
NSTEMI,	O
s/p	O
cath	O
___	O
with	O
no	O
culprit	O
lesion	O
identified.	O
#	O
CORONARIES:	O
LAD	O
50%,	O
total	O
occlusion	O
mid	O
segment,	O
D1	O
60%,	O
Cx	O
80%	O
mid	O
and	O
distal	O
RCA.	O
LIMA-LAD	O
patent,	O
SVG-OM1	O
patent,	O
SVG-PDA	O
30%	O
steonsis	O
#	O
PUMP:	O
50-55%	O
#	O
RHYTHM:	O
NSR	O
ACTIVE	O
ISSUES	O
==============	O
#CAD	O
s/p	O
CABG	O
c/b	O
NSTEMI	O
Patient	O
has	O
a	O
history	O
of	O
chronic	O
intermittent	O
chest	O
pain,	O
usually	O
relieved	O
by	O
nitro.	O
This	O
admission	O
she	O
presented	O
with	O
substernal	O
chest	O
pain	O
that	O
awoke	O
her	O
from	O
sleep,	O
not	O
improved	O
with	O
nitroglycerin.	O
She	O
presented	O
to	O
her	O
outpatient	O
provider	O
who	O
referred	O
her	O
to	O
the	O
ED.	O
EKG	O
was	O
unchanged,	O
her	O
first	O
troponin	O
was	O
negative	O
but	O
second	O
was	O
positive,	O
so	O
patient	O
was	O
started	O
on	O
hep	O
gtt,	O
aspirin	O
325mg.	O
Troponins	O
peaked	O
at	O
0.20.	O
Cath	O
___	O
without	O
clear	O
culprit	O
lesion,	O
no	O
intervention	O
performed.	O
Patient	O
was	O
discharged	O
on	O
ASA	O
81mg,	O
Plavix	O
75mg,	O
home	O
Imdur	O
was	O
increased	O
to	O
180mg	O
QD,	O
she	O
was	O
continued	O
on	O
Atorvastatin	O
80mg	O
daily.	O
Fractionated	O
home	O
metop	O
to	O
12.6mg	O
Q6.	O
#HFpEF	O
No	O
evidence	O
of	O
ongoing	O
exacerbation.	O
She	O
was	O
maintained	O
euvolemic	O
with	O
IV	O
Lasix	O
and	O
was	O
transitioned	O
to	O
torsemide	O
30mg	O
QD	O
(home	O
dose	O
prior	O
was	O
60mg	O
QD	O
furosemide).	O
___	O
was	O
held	O
in	O
the	O
setting	O
of	O
contrast	O
load	O
for	O
cath	O
and	O
was	O
restarted	O
at	O
reduced	O
dose	O
of	O
50mg	O
on	O
day	O
of	O
discharge.	O
CHRONIC	O
ISSUES	O
==============	O
#CKD	O
III:	O
At	O
baseline	O
1.1-1.4	O
in	O
setting	O
of	O
diabetes,	O
with	O
mild	O
___	O
to	O
1.6	O
in	O
the	O
setting	O
of	O
cath.	O
#COPD/Asthma:	O
Continued	O
home	O
albuterol.	O
#T2DM:	O
Continued	O
home	O
glargine	O
54U	O
breakfast,	O
SSI	O
#AS	O
s/p	O
bioprosthetic	O
AVR:	O
___	O
AS	O
murmur	O
on	O
exam,	O
otherwise	O
no	O
signs	O
or	O
symptoms	O
of	O
AS.	O
#HYPOTHYROIDISM:	O
Continued	O
home	O
levothyroxine	O
88	O
mcg	O
#GERD:	O
Continued	O
home	O
famotidine	O
TRANSITIONAL	O
ISSUES:	O
===================	O
[]	O
losartan	O
at	O
50mg	O
in	O
setting	O
of	O
___,	O
can	O
increase	O
to	O
100mg	O
as	O
outpatient	O
[]	O
BMP	O
on	O
___,	O
can	O
decrease	O
torsemide	O
or	O
hold	O
if	O
Cr	O
has	O
not	O
returned	O
to	O
baseline	O
DC	O
WEIGHT:	O
161.2	O
lb	O
DC	O
DIURESIS:	O
torsemide	O
30mg	O
QD	O
DC	O
Cr:	O
1.6	O
#	O
CODE:	O
FULL	O
CODE	O
#	O
CONTACT:	O
HCP:	O
___	O
(daughter):	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
2.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
3.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
120	O
mg	O
PO	O
DAILY	O
4.	O
Famotidine	O
20	O
mg	O
PO	O
DAILY	O
5.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
6.	O
Losartan	O
Potassium	O
100	O
mg	O
PO	O
DAILY	O
7.	O
Levothyroxine	O
Sodium	O
88	O
mcg	O
PO	O
DAILY	O
8.	O
Furosemide	O
40	O
mg	O
PO	O
QAM	O
9.	O
Furosemide	O
20	O
mg	O
PO	O
QPM	O
10.	O
Nitroglycerin	O
SL	O
0.4	O
mg	O
SL	O
Q5MIN:PRN	O
CP	O
11.	O
Glargine	O
54	O
Units	O
Breakfast	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
12.	O
Albuterol	O
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q6H:PRN	O
SOB/wheezing	O
13.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
DAILY	O
14.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
15.	O
Fluticasone	O
Propionate	O
NASAL	O
2	O
SPRY	O
NU	O
DAILY	O
16.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
17.	O
cyanocobalamin	O
(vitamin	O
B-12)	O
1,000	O
mcg	O
oral	O
DAILY	O
18.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Torsemide	O
30	O
mg	O
PO	O
DAILY	O
RX	O
*torsemide	O
10	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
DAILY	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
RX	O
*torsemide	O
20	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
DAILY	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
2.	O
Glargine	O
54	O
Units	O
Breakfast	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
HUM	O
Insulin	O
3.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
180	O
mg	O
PO	O
DAILY	O
RX	O
*isosorbide	O
mononitrate	O
120	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
DAILY	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
RX	O
*isosorbide	O
mononitrate	O
60	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
DAILY	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
4.	O
Losartan	O
Potassium	O
50	O
mg	O
PO	O
DAILY	O
RX	O
*losartan	O
50	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
DAILY	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
5.	O
Albuterol	O
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q6H:PRN	O
SOB/wheezing	O
6.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
7.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
8.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
9.	O
cyanocobalamin	O
(vitamin	O
B-12)	O
1,000	O
mcg	O
oral	O
DAILY	O
10.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
DAILY	O
11.	O
Famotidine	O
20	O
mg	O
PO	O
DAILY	O
12.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
13.	O
Fluticasone	O
Propionate	O
NASAL	O
2	O
SPRY	O
NU	O
DAILY	O
14.	O
Levothyroxine	O
Sodium	O
88	O
mcg	O
PO	O
DAILY	O
15.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
16.	O
Nitroglycerin	O
SL	O
0.4	O
mg	O
SL	O
Q5MIN:PRN	O
CP	O
17.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
PRIMARY	O
DIAGNOSIS	O
Coronary	O
Artery	O
Disease	O
Non	O
ST	O
Elevation	O
Myocardial	O
Infarct	O
SECONDARY	O
DIAGNOSIS	O
Chronic	O
Kidney	O
Disease	O
COPD/Asthma	O
Type	O
II	O
Diabetes	O
Mellitus	O
Aortic	O
Stenosis	O
Hypothyroidism	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Dementia
and	B-Dementia
coherent.	B-Dementia
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
It	O
was	O
a	O
pleasure	O
participating	O
in	O
your	O
care.	O
Please	O
read	O
through	O
the	O
following	O
information.	O
WHY	O
WAS	O
I	O
ADMITTED	O
TO	O
THE	O
HOSPITAL?	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
because	O
you	O
were	O
having	O
chest	O
pain.	O
WHAT	O
HAPPENED	O
WHILE	O
I	O
WAS	O
IN	O
THE	O
HOSPITAL?	O
While	O
you	O
were	O
here,	O
we	O
did	O
blood	O
tests	O
which	O
showed	O
you	O
had	O
a	O
heart	O
attack.	O
You	O
underwent	O
a	O
procedure	O
to	O
have	O
the	O
arteries	O
of	O
your	O
heart	O
looked	O
at.	O
None	O
of	O
the	O
arteries	O
had	O
a	O
clear	O
blockage,	O
so	O
we	O
did	O
not	O
put	O
in	O
any	O
stents.	O
You	O
were	O
treated	O
you	O
with	O
medications	O
to	O
help	O
prevent	O
blockages	O
from	O
developing	O
(Aspirin	O
and	O
Plavix).	O
WHAT	O
DO	O
YOU	O
NEED	O
TO	O
DO	O
WHEN	O
YOU	O
LEAVE	O
THE	O
HOSPITAL?	O
-	O
Take	O
all	O
of	O
your	O
medications	O
as	O
prescribed	O
(listed	O
below)	O
-	O
Follow	O
up	O
with	O
your	O
doctors	O
as	O
listed	O
below	O
-	O
Weigh	O
yourself	O
every	O
morning.	O
Your	O
weight	O
on	O
discharge	O
is	O
161	O
lb.	O
Please	O
seek	O
medical	O
attention	O
if	O
your	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs	O
(increases	O
to	O
a	O
weight	O
of	O
164).	O
-	O
Seek	O
medical	O
attention	O
if	O
you	O
have	O
new	O
or	O
concerning	O
symptoms	O
or	O
you	O
develop	O
swelling	O
in	O
your	O
legs,	O
abdominal	O
distention,	O
or	O
shortness	O
of	O
breath	O
at	O
night.	O
We	O
wish	O
you	O
the	O
best!	O
-Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

